Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vitasora Health ( (AU:VHL) ) has issued an update.
Vitasora Health Limited reported a significant increase in revenue by 256.78% to $3.7 million for the year ending June 2025, despite a rise in net losses to $10.1 million. The integration of Orb Health has resulted in substantial merger synergies, reducing monthly losses by US$148K. The company collected $1.623 million from clients between April and mid-July, improving liquidity. However, no dividends were paid, and the directors do not recommend any for the 2025 financial year.
More about Vitasora Health
Vitasora Health Limited, formerly known as Respiri Limited, operates in the healthcare industry, focusing on providing health solutions through platforms like the Ceras platform. The company has recently expanded its operations through the acquisition of Orb Health, aiming to enhance its market presence and operational efficiency.
YTD Price Performance: -65.06%
Average Trading Volume: 1,712,988
Technical Sentiment Signal: Sell
Current Market Cap: A$49.84M
See more insights into VHL stock on TipRanks’ Stock Analysis page.